Table 1.
Baseline characteristics
| Characteristic | Measure | All patients (N = 369)a |
|---|---|---|
| Age (years) | N | 369 |
| Mean ± SD (Med) | 65.8 ± 14.6 | |
| Range | (19.0–94.0) | |
| Sex | Male | 185 (50.1%) |
| Raceb | White | 334 (92.8%) |
| Black or African American | 24 (6.7%) | |
| Asian | 2 (0.6%) | |
| Other | 1 (0.3%) | |
| Height (cm) | N | 368 |
| Mean ± SD (Med) | 170.9 ± 10.5 | |
| Range | (132.1–198.1) | |
| Weight (kg) | N | 368 |
| Mean ± SD (Med) | 88.7 ± 23.8 | |
| Range | (44.4–208.7) | |
| Comorbidities | COPD | 26 (7.1%) |
| Syncope | 137 (37.2%) | |
| Diabetes | 86 (23.4%) | |
| Cerebrovascular disease | 75 (20.4%) | |
| Cryptogenic stroke | 48 (64.0%) | |
| Peripheral vascular disease | 21 (5.7%) | |
| Renal dysfunction | 37 (10.1%) | |
| Hypertension | 263 (71.5%) | |
| Hyperlipidemia | 206 (56.0%) | |
| Anemia | 24 (6.5%) | |
| Sleep apnea | 77 (20.9%) | |
| History of disease/risk factorsb | Heart failure | 42 (11.4%) |
| Ischemic heart disease | 39 (10.6%) | |
| Valvular disease | 45 (12.2%) | |
| COVID‐19 | 13 (7.4%) |
a
Percentages calculated out of total patients with non‐missing values.
b
Patients may contribute to more than one measure.